Navigation Links
FDA Grants Standard Review for GSK's Experimental HPV Vaccine Cervarix

GlaxoSmithKline on Thursday announced that FDA has granted a standard 10-month review of its experimental human papillomavirus vaccine Cervarix, Reuters reports. A GSK spokesperson on Thursday said FDA declined to grant priority review, which could have been completed in six months.

Cervarix and Merck's HPV vaccine Gardasil have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases. Researchers in a 2006 study published in the online edition of the Lancet also found that Cervarix prevented infection with HPV strains 31 and 45, which together with strains 16 and 18 cause more than 80% of cervical cancer cases. GSK in January announced that it would begin a trial to determine whether Cervarix provides better protection against cervical cancer than Gardasil.

The Australian Therapeutic Goods Administration last week granted the first major market license for Cervarix, approving the vaccine for girls and women ages 10 to 45. According to Reuters, the European Medicines Agency could recommend the vaccine next month. FDA will most likely take action on GSK's application in January 2008, according to analysts at Evolution Securities.


'"/>




Page: 1

Related medicine news :

1. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
2. Rice University wins Prestigious Grants from HHMI
3. Norway Grants $80 mn to Indias Health Mission
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. NIMH Grants Funds To Study The Impact Of Terrorism
6. US Grants Rs.190 mn to Fight TB in India
7. Gates Foundation Grants $23mn for AIDS programme in India
8. FDA Grants Approval to First Bird Flu Vaccine
9. Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses
10. Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses
11. Angioplasty Should be the Standard
Post Your Comments:
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 LINET ... Award of Charlotte in the small business category. The ... The Mayor’s International Community Award is given on an ... area that exhibit outstanding contributions to philanthropy. Since ... the Mayor have hosted the Mayor’s International Community Awards. ...
(Date:5/6/2015)... Lewisville, TX (PRWEB) May 06, 2015 ... (NYSE:ADPT) opened its first freestanding emergency room in Chandler ... Dignity Health Arizona General Hospital, which is also part ... To celebrate the grand opening, Dignity Health Arizona General ... the Chandler Chamber of Commerce and donated $5,000 to ...
(Date:5/5/2015)... It’s not your usual Veterans Affairs outreach ... cars and motorcycles to the 3rd Annual “Crusin Lincoln” Show ... at the Lincoln VA Clinic, 600 S. 70th St. , ... out each other’s rides, but also to talk to employees ... , Staff from the VA Nebraska-Western Iowa Health Care ...
(Date:5/5/2015)... 05, 2015 With the FCPX LUT: Monochromatic ... and easily add washed color grades to footage. A LUT ... modifying an image. The LUT changes every pixel's color to ... with 90 washed CUBE LUT files. , This plugin was ... give any footage a washed look. , CUBE LUT ...
(Date:5/5/2015)... The Journal of Pain Research has ... improve the management of chronic non-cancer pain in ... program ” , As corresponding author Professor Lyne ... and family members, managers, and researcher, identified challenges ... “work in silos”, lack of awareness regarding chronic ...
Breaking Medicine News(10 mins):Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 3Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2
... Americans will be diagnosed at some point in their lives ... One of the most common types, especially among women, is ... will be diagnosed with breast cancer in 2009, and more ... alone. One of the professions at the frontlines in ...
... , Teva Pharmaceuticals Hosting Local Roundtable as ... , PHILADELPHIA, JULY 24 According ... between 2000 and 2007. In an effort to bring awareness ... leading generic pharmaceutical company, is hosting a roundtable forum on July ...
... drop in estrogen, experts say , FRIDAY, July 24 ... involves removal of both ovaries, nearly doubles a younger ... study has found. , "It,s possible that vulnerability to ... in estrogen levels or potentially long-term use of hormone ...
... , PITTSBURGH, July 24 ... organizations in Pennsylvania to assist programs that are supported by ... Grant Program, which reinforces the company,s appreciation for those employees ... , Highmark recognizes that its ...
... PITTSBURGH, July 24 Cardiorobotics, Inc., a medical device company ... of surgical and interventional applications has closed on an $11.6 ... was led by Eagle Ventures and its co-investors, the Pittsburgh ... investors. , , Funds raised ...
... COLUMBIA, S.C., July 24 UCI Medical Affiliates, ... the former Executive Vice-President of Finance, Chief Financial Officer, and ... on July 23, 2009 in federal court to criminal charges ... the Securities and Exchange Commission. On the eight reports ...
Cached Medicine News:Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 2Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 3Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 4Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 5Health News:Government Officials, Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 2Health News:Ovary Removal May Play a Role in Lung Cancer 2Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 2Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 3Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 4Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 5Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 6Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 7Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 8Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 9Health News:Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery 2Health News:Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery 3Health News:Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery 4Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to Former Executive Officer Pleading Guilty to Criminal Charges 2
(Date:5/5/2015)... May 5, 2015 Silver Creek Pharmaceuticals, Inc. ... Research (SBIR) grant from the National Institute of Health ... San Francisco based biotechnology company that ... tissues damaged by disease. This award will be used ... heart tissue following a heart attack. Silver ...
(Date:5/5/2015)... May 5, 2015 GW Pharmaceuticals plc ... a biopharmaceutical company focused on discovering, developing and ... platform, announced today the closing of the previously ... GW of 1,600,000 American Depositary Shares (ADSs) at ... proceeds of approximately $179.2 million (before deducting underwriting ...
(Date:5/5/2015)...  IBM Watson Health (NYSE: IBM ) today announced ... Mayo Clinic to advance patient health by applying the ... As Watson,s capabilities are applied to EHRs, ... of the medical factors that could impact an individual,s health ... customers – some of the largest and most-recognized healthcare ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4
... 5, 2011 Jennerex, Inc., a private clinical-stage ... of first-in-class targeted oncolytic products for cancer, and ... specialized in the development of immunotherapeutic products, today ... 2 clinical studies of JX-594 were presented in ...
... Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced preliminary ... The Company announced the preliminary metrics in advance of the ... Executive Officer of Questcor, will present on Tuesday, April 5, ... web cast of the presentation during or after the event, ...
Cached Medicine Technology:Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 2Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 3Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 4Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 2Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 3Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 4Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 6Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 7Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 8
...
Designed to minimize emblolic debris in SVGs and carotids...
... EECP therapy extends the ability ... to treat coronary artery disease, and ... of participating in the treatment of ... drugs. Vasomedical's EECP therapy provides a ...
... The dual lumen petite ... 1.0 mm catheter (each lumen) ... Dual oval lumen catheters offer ... maximum catheter strength. Dual lumen ...
Medicine Products: